advisorsecurities master

LSTALisata Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
18205
Ticker
LSTA
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
1999-03-01
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
LSTA

Detail

Enriched 2026-08-14 20:47

Market cap
$10,632,905.66
Shares outstanding (class)
9,010,937
Shares outstanding (weighted)
9,010,937
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
21
Location
BASKING RIDGE, NJ
Description

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data